| Antiinflammatory therapy with canakinumab for atherosclerotic disease PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ... New England journal of medicine 377 (12), 1119-1131, 2017 | 8099 | 2017 |
| Alogliptin after acute coronary syndrome in patients with type 2 diabetes WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ... New England journal of medicine 369 (14), 1327-1335, 2013 | 3131 | 2013 |
| Alirocumab and cardiovascular outcomes after acute coronary syndrome GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, ... New England Journal of Medicine 379 (22), 2097-2107, 2018 | 2811 | 2018 |
| Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial DR Holmes, VY Reddy, ZG Turi, SK Doshi, H Sievert, M Buchbinder, ... The Lancet 374 (9689), 534-542, 2009 | 2566 | 2009 |
| Everolimus-eluting stents or bypass surgery for left main coronary artery disease GW Stone, JF Sabik, PW Serruys, CA Simonton, P Généreux, J Puskas, ... New England Journal of Medicine 375 (23), 2223-2235, 2016 | 1170 | 2016 |
| Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial VY Reddy, H Sievert, J Halperin, SK Doshi, M Buchbinder, P Neuzil, ... Jama 312 (19), 1988-1998, 2014 | 920 | 2014 |
| Long-term results of stenting versus endarterectomy for carotid-artery stenosis TG Brott, G Howard, GS Roubin, JF Meschia, A Mackey, W Brooks, ... New England Journal of Medicine 374 (11), 1021-1031, 2016 | 789 | 2016 |
| Everolimus-eluting bioresorbable scaffolds for coronary artery disease SG Ellis, DJ Kereiakes, DC Metzger, RP Caputo, DG Rizik, PS Teirstein, ... New England Journal of Medicine 373 (20), 1905-1915, 2015 | 746 | 2015 |
| Five-year outcomes after PCI or CABG for left main coronary disease GW Stone, AP Kappetein, JF Sabik, SJ Pocock, MC Morice, J Puskas, ... New England Journal of Medicine 381 (19), 1820-1830, 2019 | 718 | 2019 |
| Randomized trial of stent versus surgery for asymptomatic carotid stenosis K Rosenfield, JS Matsumura, S Chaturvedi, T Riles, GM Ansel, ... New England Journal of Medicine 374 (11), 1011-1020, 2016 | 648 | 2016 |
| Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial GG Schwartz, L Bessac, LG Berdan, DL Bhatt, V Bittner, R Diaz, ... American heart journal 168 (5), 682-689. e1, 2014 | 571 | 2014 |
| Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial BK Lal, KW Beach, GS Roubin, HL Lutsep, WS Moore, MB Malas, D Chiu, ... The Lancet Neurology 11 (9), 755-763, 2012 | 465 | 2012 |
| Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk AD Pradhan N Engl J Med 387 (21), 1923-1934, 2022 | 379* | 2022 |
| Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative MB Basir, NK Kapur, K Patel, MA Salam, T Schreiber, A Kaki, I Hanson, ... Catheterization and Cardiovascular Interventions 93 (7), 1173-1183, 2019 | 372 | 2019 |
| The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ... Journal of the American College of Cardiology 69 (7), 777-785, 2017 | 343 | 2017 |
| Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for … SG Goodman, DM Wojdyla, JP Piccini, HD White, JF Paolini, CC Nessel, ... Journal of the American College of Cardiology 63 (9), 891-900, 2014 | 285 | 2014 |
| Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results CJ White, SS Iyer, LN Hopkins, BT Katzen, ME Russell Catheterization and Cardiovascular Interventions 67 (4), 503-512, 2006 | 283 | 2006 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 263 | 2019 |
| Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the REVEAL AF study JA Reiffel, A Verma, PR Kowey, JL Halperin, BJ Gersh, R Wachter, ... JAMA cardiology 2 (10), 1120-1127, 2017 | 262 | 2017 |
| Protected carotid stenting in high-risk patients with severe carotid artery stenosis RD Safian, JF Bresnahan, MR Jaff, M Foster, JM Bacharach, B Maini, ... Journal of the American College of Cardiology 47 (12), 2384-2389, 2006 | 228 | 2006 |
Michael SzarekUniversity of Colorado; SUNY Downstate Health Sciences UniversityVerified email at downstate.edu